T1	Participants 21 44	advanced breast cancer.
T2	Participants 67 135	600 cases in a cooperative programme to carry out a systematic study
T3	Participants 271 294	advanced breast cancers
T4	Participants 362 421	departments of medicine in eight French anticancer centres.
T5	Participants 568 580	603 patients
T6	Participants 1103 1123	series of 240 cases.
